The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care

Cancer

Volumn 117, Issue 1, 2011, Pages 180-189

  Freedman, Rachel A ^a   Virgo, Katherine S ^b   He, Yulei ^c   Pavluck, Alexandre L ^b   Winer, Eric P ^a   Ward, Elizabeth M ^b   Keating, Nancy L ^c,d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

breast cancer; disparity; insurance; race; socioeconomic status

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER STAGING; CANCER THERAPY; CAUCASIAN; COHORT ANALYSIS; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE DISPARITY; HEALTH INSURANCE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICARE; NEGRO; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; RACE DIFFERENCE; SOCIAL STATUS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HORMONES; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; MASTECTOMY; RADIOTHERAPY, ADJUVANT; SOCIAL CLASS; SOCIOECONOMIC FACTORS;

EID: 78650702699     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25542     Document Type: Article

References (38)

1. National Cancer Institute (NCI). Breast Cancer Treatment (PDQ). Health Professional Version, 2008. http://www.nci. nih.gov/cancertopics/pdq/treatment/ breast/healthprofessional/page7#section-108 Accessed September, 2009.
2. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Breast Cancer., V. 2. 2009.
3. Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J., Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol. 2006; 24: 2268-2275.
4. Bickell NA, Wang JJ, Oluwole S, et al. Missed opportunities: racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006; 24: 1357-1362.
5. Freedman RA, He Y, Winer EP, Keating NL., Trends in racial and age disparities in definitive local therapy of early-stage breast cancer. J Clin Oncol. 2009; 27: 713-719.
6. Gross CP, Smith BD, Wolf E, Andersen M., Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer. 2008; 112: 900-908.
7. Hershman D, Weinberg M, Rosner Z, et al. Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst. 2003; 95: 1545-158.
8. Griggs JJ, Sorbero ME, Stark AT, Heininger SE, Dick AW., Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat. 2003; 81: 21-31.
9. Jatoi I, Anderson WF, Rao SR, Devesa SS., Breast cancer trends among black and white women in the United States. J Clin Oncol. 2005; 23: 7836-7841.
10. Commission on Cancer. National Cancer Data Base http:// www.facs.org/cancer/ncdb/index.html. Accessed August 15, 2009.
11. Menck HR, Cunningham MP, Jessup JM, et al. The growth and maturation of the National Cancer Data Base. Cancer. 1997; 80: 2296-2304.
12. Menck HR, Garfinkel L, Dodd GD., Preliminary report of the National Cancer Data Base. CA Cancer J Clin. 1991; 41: 7-18.
13. Menck HR, Jessup JM, Eyre HJ, et al. Clinical highlights from the National Cancer Data Base: 1997. CA Cancer J Clin. 1997; 47: 161-170.
14. Facility Oncology Registry Data Standards (FORDS) Manual; In:, Phillips, JL, Stewart, AK, eds.: American College of Surgeons and Committee on Cancer Revised; 2004. http:// www.facs.org/cancer/coc/fords/fordsrevised0904.pdf Accessed on August 15, 2009.
15. American College of Surgeons, Commission on Cancer. National Cancer Data Base. Cancer Program Accreditation: Categories of Approval. http://www.facs.org/ cancer/coc/categories. html#thcp. Accessed August 15, 2009.
16. US Department of Commerce Economics and Statistics Administration. US Census Bureau, Geography Division. Census Regions and Divisions of the United States. http:// www.census.gov/geo/www/us-regdiv.pdf. Accessed August 15, 2009.
17. Fleming I, Cooper J, Henson D, et al. AJCC Staging Manual. 5th ed. Philadelphia, PA: Lippincott -Raven; 1997.
18. Green F, Page D, Fleming I, et al. AJCC Cancer Staging Manual, 6th ed. New York: Springer- Verlag; 2002
19. Lund MJ, Brawley OP, Ward KC, Young JL, Gabram SS, Eley JW., Parity and disparity in first course treatment of invasive breast cancer. Breast Cancer Res Treat. 2007; 109: 545-557.
20. Shavers VL, Harlan LC, Stevens JL., Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer. 2003; 97: 134-147.
21. Haggstrom DA, Quale C, Smith-Bindman R., Differences in the quality of breast cancer care among vulnerable populations. Cancer. 2005; 104: 2347-2358.
22. Bhargava A, Du XL., Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer. Cancer. 2009; 115: 2999-3008.
23. Iezzoni LI, Ngo LH, Li D, Roetzheim RG, Drews RE, McCarthy EP., Early stage breast cancer treatments for younger medicare beneficiaries with different disabilities. Health Serv Res. 2008; 43: 1752-1767.
24. McCarthy EP, Ngo LH, Roetzheim RG, et al. Disparities in breast cancer treatment and survival for women with disabilities. Ann Intern Med. 2006; 145: 637-645.
25. Short LJ, Fisher MD, Wahl PM, et al. Disparities in medical care among commercially insured patients with newly diagnosed breast cancer: opportunities for intervention. Cancer. 2009; 116: 193-202.
26. Newman LA, Mason J, Cote D, et al. African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African-American and 40,000 White American patients with carcinoma of the breast. Cancer. 2002; 94: 2844-2854.
27. Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA., Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol. 2006; 24: 1342-139.
28. Gerend MA, Pai M., Social determinants of Black-White disparities in breast cancer mortality: a review. Cancer Epidemiol Biomarkers Prev. 2008; 17: 2913-2923.
29. Masi CM, Gehlert S., Perceptions of breast cancer treatment among African-American women and men: implications for interventions. J Gen Intern Med. 2009; 24: 408-414.
30. Bickell NA, Weidmann J, Fei K, Lin JJ, Leventhal H., Underuse of breast cancer adjuvant treatment: patient knowledge, beliefs, and medical mistrust. J Clin Oncol. 2009; 27: 5160-517.
31. Chen JY, Diamant AL, Thind A, Maly RC., Determinants of breast cancer knowledge among newly diagnosed, low-income, medically underserved women with breast cancer. Cancer. 2008; 112: 1153-1161.
32. Bickell NA, LePar F, Wang JJ, Leventhal H., Lost opportunities: physicians' reasons and disparities in breast cancer treatment. J Clin Oncol. 2007; 25: 2516-2521.
33. Keating NL, Kouri E, He Y, Weeks JC, Winer EP., Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery? Med Care. 2009; 47: 765-773.
34. Schrag D, Virnig BA, Warren JL., Linking tumor registry and Medicaid claims to evaluate cancer care delivery. Health Care Financ Rev. 2009; 30: 61-73.
35. Krieger N, Chen JT, Ware JH, Kaddour A., Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions. Cancer Causes Control. 2008; 19: 1305-1318.
36. Malin JL, Kahn KL, Adams J, Kwan L, Laouri M, Ganz PA., Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst. 2002; 94: 835-844. (Pubitemid 34705055)
37. National Institutes of Health Consensus Development program. Adjuvant Therapy for Breast Cancer. Consensus Development Conference Statement. November 1-3, 2000. http://consensus.nih.gov/2000/2000AdjuvantTherapyBreast Cancer114html.htm. Accessed on November 4, 2009.
38. Bilimoria KY, Bentrem DJ, Stewart AK, Winchester DP, Ko CY., Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. J Clin Oncol. 2009; 27: 4177-4181.